Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.

Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, DeTure M, Vanderburg CR, Corjuc BT, DeVos SL, Gonzalez JA, Chew J, Vidensky S, Gage FH, Mertens J, Troncoso J, Mandelkow E, Salvatella X, Lim RYH, Petrucelli L, Wegmann S, Rothstein JD, Hyman BT.

Neuron. 2019 Jan 16;101(2):349. doi: 10.1016/j.neuron.2018.12.031. No abstract available.

2.

Health care utilization after hospitalization following a road traffic accident.

Van Belleghem G, Van Deynse H, Devos S, Huysmans E, Hubloue I, Lauwaert D, Pien K, Pouliart N, Buyl R, Putman K.

Disabil Rehabil. 2019 Jan 7:1-8. doi: 10.1080/09638288.2018.1531152. [Epub ahead of print]

PMID:
30616397
3.

Aggression towards the GP: can we profile the GP-victim? A cross-section survey among GPs.

Demeur V, Devos S, Jans E, Schoenmakers B.

BJGP Open. 2018 Sep 19;2(3):bjgpopen18X101604. doi: 10.3399/bjgpopen18X101604. eCollection 2018 Oct.

4.

The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.

Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D, Hyman BT.

J Neuroinflammation. 2018 Sep 18;15(1):269. doi: 10.1186/s12974-018-1309-z.

5.

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.

Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, DeTure M, Vanderburg CR, Corjuc BT, DeVos SL, Gonzalez JA, Chew J, Vidensky S, Gage FH, Mertens J, Troncoso J, Mandelkow E, Salvatella X, Lim RYH, Petrucelli L, Wegmann S, Rothstein JD, Hyman BT.

Neuron. 2018 Sep 5;99(5):925-940.e7. doi: 10.1016/j.neuron.2018.07.039. Erratum in: Neuron. 2019 Jan 16;101(2):349.

PMID:
30189209
6.

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain.

DeVos SL, Corjuc BT, Oakley DH, Nobuhara CK, Bannon RN, Chase A, Commins C, Gonzalez JA, Dooley PM, Frosch MP, Hyman BT.

Front Neurosci. 2018 Apr 24;12:267. doi: 10.3389/fnins.2018.00267. eCollection 2018.

7.

Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.

DeVos SL, Corjuc BT, Commins C, Dujardin S, Bannon RN, Corjuc D, Moore BD, Bennett RE, Jorfi M, Gonzales JA, Dooley PM, Roe AD, Pitstick R, Irimia D, Frosch MP, Carlson GA, Hyman BT.

Brain. 2018 Jul 1;141(7):2194-2212. doi: 10.1093/brain/awy117.

PMID:
29733334
8.

Time Gain Needed for In-Ambulance Telemedicine: Cost-Utility Model.

Valenzuela Espinoza A, Devos S, van Hooff RJ, Fobelets M, Dupont A, Moens M, Hubloue I, Lauwaert D, Cornu P, Brouns R, Putman K.

JMIR Mhealth Uhealth. 2017 Nov 24;5(11):e175. doi: 10.2196/mhealth.8288.

9.

Reproducibility of capillaroscopic classifications of systemic sclerosis: results from the SCLEROCAP study.

Boulon C, Devos S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Blaise S, Sintes P, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J.

Rheumatology (Oxford). 2017 Oct 1;56(10):1713-1720. doi: 10.1093/rheumatology/kex246.

PMID:
28957554
10.

Variations in hospital costs after traffic injuries: The importance of sociodemographic aspects and comorbidities.

Devos S, Van Belleghem G, Pien K, Hubloue I, Lauwaert I, van Lier T, Annemans L, Putman K.

Injury. 2017 Oct;48(10):2132-2139. doi: 10.1016/j.injury.2017.08.009. Epub 2017 Aug 5.

PMID:
28838595
11.

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.

Brown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre SE, Tam CS, Mulligan SP, Jaeger U, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Thornton P, Caligaris-Cappio F, Delgado J, Montillo M, DeVos S, Moreno C, Pagel JM, Munir T, Burger JA, Chung D, Lin J, Gau L, Chang B, Cole G, Hsu E, James DF, Byrd JC.

Leukemia. 2018 Jan;32(1):83-91. doi: 10.1038/leu.2017.175. Epub 2017 Jun 8.

12.

Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.

Nicholls SB, DeVos SL, Commins C, Nobuhara C, Bennett RE, Corjuc DL, Maury E, Eftekharzadeh B, Akingbade O, Fan Z, Roe AD, Takeda S, Wegmann S, Hyman BT.

PLoS One. 2017 May 22;12(5):e0177914. doi: 10.1371/journal.pone.0177914. eCollection 2017.

13.

Tau at the Crossroads between Neurotoxicity and Neuroprotection.

DeVos SL, Hyman BT.

Neuron. 2017 May 17;94(4):703-704. doi: 10.1016/j.neuron.2017.05.001.

14.

Enhanced Tau Aggregation in the Presence of Amyloid β.

Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, Roe AD, Frosch MP, Pitstick R, Carlson GA, Hyman BT.

Am J Pathol. 2017 Jul;187(7):1601-1612. doi: 10.1016/j.ajpath.2017.03.011. Epub 2017 May 10.

15.

Membrane vesicle secretion and prophage induction in multidrug-resistant Stenotrophomonas maltophilia in response to ciprofloxacin stress.

Devos S, Van Putte W, Vitse J, Van Driessche G, Stremersch S, Van Den Broek W, Raemdonck K, Braeckmans K, Stahlberg H, Kudryashev M, Savvides SN, Devreese B.

Environ Microbiol. 2017 Oct;19(10):3930-3937. doi: 10.1111/1462-2920.13793. Epub 2017 Jun 22.

PMID:
28488744
16.

Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.

Nobuhara CK, DeVos SL, Commins C, Wegmann S, Moore BD, Roe AD, Costantino I, Frosch MP, Pitstick R, Carlson GA, Hock C, Nitsch RM, Montrasio F, Grimm J, Cheung AE, Dunah AW, Wittmann M, Bussiere T, Weinreb PH, Hyman BT, Takeda S.

Am J Pathol. 2017 Jun;187(6):1399-1412. doi: 10.1016/j.ajpath.2017.01.022. Epub 2017 Apr 11.

17.

Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.

DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, Chen G, Shen T, Tran H, Nichols B, Zanardi TA, Kordasiewicz HB, Swayze EE, Bennett CF, Diamond MI, Miller TM.

Sci Transl Med. 2017 Jan 25;9(374). pii: eaag0481. doi: 10.1126/scitranslmed.aag0481.

18.

Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.

Marquié M, Normandin MD, Meltzer AC, Siao Tick Chong M, Andrea NV, Antón-Fernández A, Klunk WE, Mathis CA, Ikonomovic MD, Debnath M, Bien EA, Vanderburg CR, Costantino I, Makaretz S, DeVos SL, Oakley DH, Gomperts SN, Growdon JH, Domoto-Reilly K, Lucente D, Dickerson BC, Frosch MP, Hyman BT, Johnson KA, Gómez-Isla T.

Ann Neurol. 2017 Jan;81(1):117-128. doi: 10.1002/ana.24844.

19.

The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis.

Depluverez S, Devos S, Devreese B.

Front Microbiol. 2016 Aug 30;7:1336. doi: 10.3389/fmicb.2016.01336. eCollection 2016. Review.

20.

Long-term impact of stroke on patients' health-related quality of life.

De Wit L, Theuns P, Dejaeger E, Devos S, Gantenbein AR, Kerckhofs E, Schuback B, Schupp W, Putman K.

Disabil Rehabil. 2017 Jul;39(14):1435-1440. doi: 10.1080/09638288.2016.1200676. Epub 2016 Jul 6.

PMID:
27385479
21.

Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.

Takeda S, Commins C, DeVos SL, Nobuhara CK, Wegmann S, Roe AD, Costantino I, Fan Z, Nicholls SB, Sherman AE, Trisini Lipsanopoulos AT, Scherzer CR, Carlson GA, Pitstick R, Peskind ER, Raskind MA, Li G, Montine TJ, Frosch MP, Hyman BT.

Ann Neurol. 2016 Sep;80(3):355-67. doi: 10.1002/ana.24716. Epub 2016 Aug 3.

22.

Effect of the shape of the exposure-response function on estimated hospital costs in a study on non-elective pneumonia hospitalizations related to particulate matter.

Devos S, Cox B, van Lier T, Nawrot TS, Putman K.

Environ Int. 2016 Sep;94:525-530. doi: 10.1016/j.envint.2016.06.012. Epub 2016 Jun 21.

PMID:
27342649
23.

Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model.

Schoch KM, DeVos SL, Miller RL, Chun SJ, Norrbom M, Wozniak DF, Dawson HN, Bennett CF, Rigo F, Miller TM.

Neuron. 2016 Jun 1;90(5):941-7. doi: 10.1016/j.neuron.2016.04.042. Epub 2016 May 19.

24.

Direct cost saving potential in medication costs due to a reduction in outdoor air pollution for the Brussels Capital Region.

Simons K, Devos S, Putman K, Coomans D, Van Nieuwenhuyse A, Buyl R.

Sci Total Environ. 2016 Aug 15;562:760-765. doi: 10.1016/j.scitotenv.2016.04.022. Epub 2016 Apr 22.

PMID:
27110987
25.

Intra- and Interspecies Effects of Outer Membrane Vesicles from Stenotrophomonas maltophilia on β-Lactam Resistance.

Devos S, Stremersch S, Raemdonck K, Braeckmans K, Devreese B.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2516-8. doi: 10.1128/AAC.02171-15. Print 2016 Apr.

26.

Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.

Wegmann S, Maury EA, Kirk MJ, Saqran L, Roe A, DeVos SL, Nicholls S, Fan Z, Takeda S, Cagsal-Getkin O, William CM, Spires-Jones TL, Pitstick R, Carlson GA, Pooler AM, Hyman BT.

EMBO J. 2015 Dec 14;34(24):3028-41. doi: 10.15252/embj.201592748. Epub 2015 Nov 4.

27.

Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.

Takeda S, Wegmann S, Cho H, DeVos SL, Commins C, Roe AD, Nicholls SB, Carlson GA, Pitstick R, Nobuhara CK, Costantino I, Frosch MP, Müller DJ, Irimia D, Hyman BT.

Nat Commun. 2015 Oct 13;6:8490. doi: 10.1038/ncomms9490.

28.

Predicting in-hospital mortality of traffic victims: A comparison between AIS-and ICD-9-CM-related injury severity scales when only ICD-9-CM is reported.

Van Belleghem G, Devos S, De Wit L, Hubloue I, Lauwaert D, Pien K, Putman K.

Injury. 2016 Jan;47(1):141-6. doi: 10.1016/j.injury.2015.08.025. Epub 2015 Aug 25.

PMID:
26429105
29.

Cost saving potential in cardiovascular hospital costs due to reduction in air pollution.

Devos S, Cox B, Dhondt S, Nawrot T, Putman K.

Sci Total Environ. 2015 Sep 15;527-528:413-9. doi: 10.1016/j.scitotenv.2015.04.104. Epub 2015 May 14.

PMID:
25981939
30.

The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia.

Devos S, Van Oudenhove L, Stremersch S, Van Putte W, De Rycke R, Van Driessche G, Vitse J, Raemdonck K, Devreese B.

Front Microbiol. 2015 Apr 14;6:298. doi: 10.3389/fmicb.2015.00298. eCollection 2015.

31.

Xanthoma disseminatum: case report and mini-review of the literature.

Park M, Boone B, Devos S.

Acta Dermatovenerol Croat. 2014;22(2):150-4. Review.

PMID:
25102803
32.

Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A, Barker SJ, Foley AC, Thorpe JR, Serpell LC, Miller TM, Grinberg LT, Seeley WW, Diamond MI.

Neuron. 2014 Jun 18;82(6):1271-88. doi: 10.1016/j.neuron.2014.04.047. Epub 2014 May 22.

33.

GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.

Meuris L, Santens F, Elson G, Festjens N, Boone M, Dos Santos A, Devos S, Rousseau F, Plets E, Houthuys E, Malinge P, Magistrelli G, Cons L, Chatel L, Devreese B, Callewaert N.

Nat Biotechnol. 2014 May;32(5):485-9. doi: 10.1038/nbt.2885. Epub 2014 Apr 20.

PMID:
24752077
34.

Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Triplett WT, Baligand C, Forbes SC, Willcocks RJ, Lott DJ, DeVos S, Pollaro J, Rooney WD, Sweeney HL, Bönnemann CG, Wang DJ, Vandenborne K, Walter GA.

Magn Reson Med. 2014 Jul;72(1):8-19. doi: 10.1002/mrm.24917. Epub 2013 Sep 4.

35.

Antisense reduction of tau in adult mice protects against seizures.

DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR, Schuler DR, Maloney SE, Wozniak DF, Rigo F, Bennett CF, Cirrito JR, Holtzman DM, Miller TM.

J Neurosci. 2013 Jul 31;33(31):12887-97. doi: 10.1523/JNEUROSCI.2107-13.2013.

36.

Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds.

Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, Ouidja MO, Brodsky FM, Marasa J, Bagchi DP, Kotzbauer PT, Miller TM, Papy-Garcia D, Diamond MI.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3138-47. doi: 10.1073/pnas.1301440110. Epub 2013 Jul 29.

37.

Direct intraventricular delivery of drugs to the rodent central nervous system.

DeVos SL, Miller TM.

J Vis Exp. 2013 May 12;(75):e50326. doi: 10.3791/50326.

38.

Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy.

Forbes SC, Walter GA, Rooney WD, Wang DJ, DeVos S, Pollaro J, Triplett W, Lott DJ, Willcocks RJ, Senesac C, Daniels MJ, Byrne BJ, Russman B, Finkel RS, Meyer JS, Sweeney HL, Vandenborne K.

Radiology. 2013 Oct;269(1):198-207. doi: 10.1148/radiol.13121948. Epub 2013 May 21.

39.

Antisense oligonucleotides: treating neurodegeneration at the level of RNA.

DeVos SL, Miller TM.

Neurotherapeutics. 2013 Jul;10(3):486-97. doi: 10.1007/s13311-013-0194-5. Review.

40.

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant.

Arai S, Fanale M, DeVos S, Engert A, Illidge T, Borchmann P, Younes A, Morschhauser F, McMillan A, Horning SJ.

Leuk Lymphoma. 2013 Nov;54(11):2531-3. doi: 10.3109/10428194.2013.798868. Epub 2013 Jun 5. No abstract available.

PMID:
23617324
41.

Sunscreen use and skin protection behaviour on the Belgian beach: a comparison 9 years later.

Devos SA, Van der Endt JD, Broeckx W, Vandaele M, del Marmol V, Roseeuw D, Maselis T.

Eur J Cancer Prev. 2012 Sep;21(5):474-7. doi: 10.1097/CEJ.0b013e328350b084.

PMID:
22273847
42.

Implicating calpain in tau-mediated toxicity in vivo.

Reinecke JB, DeVos SL, McGrath JP, Shepard AM, Goncharoff DK, Tait DN, Fleming SR, Vincent MP, Steinhilb ML.

PLoS One. 2011;6(8):e23865. doi: 10.1371/journal.pone.0023865. Epub 2011 Aug 17.

43.

Inhibition of in vitro cytokine production by human peripheral blood mononuclear cells treated with xenobiotics: implications for the prediction of general toxicity and immunotoxicity.

Kooijman R, Devos S, Hooghe-Peters E.

Toxicol In Vitro. 2010 Sep;24(6):1782-9. doi: 10.1016/j.tiv.2010.07.007. Epub 2010 Jul 13.

PMID:
20633635
44.

Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitro.

Kutluay SB, DeVos SL, Klomp JE, Triezenberg SJ.

J Virol. 2009 Apr;83(8):3436-49. doi: 10.1128/JVI.02349-08. Epub 2009 Jan 28.

45.

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.

Hsi ED, Jung SH, Lai R, Johnson JL, Cook JR, Jones D, Devos S, Cheson BD, Damon LE, Said J.

Leuk Lymphoma. 2008 Nov;49(11):2081-90. doi: 10.1080/10428190802419640.

46.

Relevance of positive patch-test reactions to fragrance mix.

Devos SA, Constandt L, Tupker RA, Noz KC, Lucker GP, Bruynzeel DP, Schuttelaar ML, Kruyswijk MR, van Zuuren EJ, Vink J, Coenraads PJ, Kiemeney LA, van der Valk PG.

Dermatitis. 2008 Jan-Feb;19(1):43-7.

PMID:
18346396
47.

Plant hormones: a key in clubroot development.

Devos S, Prinsen E.

Commun Agric Appl Biol Sci. 2006;71(3 Pt B):869-72. No abstract available.

PMID:
17390833
48.

Hand and forearm dermatoses among veterinarians.

Bulcke DM, Devos SA.

J Eur Acad Dermatol Venereol. 2007 Mar;21(3):360-3.

PMID:
17309459
49.

A hormone and proteome approach to picturing the initial metabolic events during Plasmodiophora brassicae infection on Arabidopsis.

Devos S, Laukens K, Deckers P, Van Der Straeten D, Beeckman T, Inzé D, Van Onckelen H, Witters E, Prinsen E.

Mol Plant Microbe Interact. 2006 Dec;19(12):1431-43.

50.

Computer-assisted total knee arthroplasty: comparative results in a preliminary series of 72 cases.

Zorman D, Etuin P, Jennart H, Scipioni D, Devos S.

Acta Orthop Belg. 2005 Dec;71(6):696-702.

PMID:
16459860

Supplemental Content

Support Center